CRISPR-Cas editing of C. albicans holds promise for overcoming deadly fungal infections

Friday, April 3, 2015 - 13:00 in Biology & Nature

By modifying the CRISPR-Cas genome editing system, Whitehead Institute researchers are now able to manipulate Candida albicans' genome systematically—an approach that could help identify novel targets for therapies against this serious pathogen for which there are a limited number of anti-fungal agents.

Read the whole article on Physorg

More from Physorg

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net